SSRIs and Self-harm in Borderline Personality Disorder.

Trial Profile

SSRIs and Self-harm in Borderline Personality Disorder.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Apr 2015

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Borderline personality disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Apr 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 21 Dec 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 21 Dec 2010 Actual initiation date (September 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top